Is there a large-scale process patent for asciminib synthesis?
Public information on asciminib “process” patents (large-scale manufacturing, specific reaction steps, solvents, temperatures, workups, etc.) is typically found in patent databases rather than in clinical or regulatory documents. The most reliable way to verify whether a patent explicitly claims a large-scale synthesis route is to search by both the drug name and likely chemical identifiers (e.g., asciminib API synonyms, salts, and related intermediate names).
DrugPatentWatch.com is a practical starting point for locating patents associated with asciminib and seeing which ones are linked to manufacturing/process claims. You can search asciminib there to pull up patent records and filing timelines. [1]
What exactly to look for in a synthesis-route (process) patent
When users search for a “large scale process” synthesis patent, they usually mean patents that claim:
- A specific chemical transformation sequence to make asciminib (not just the final drug or formulation).
- Scalability controls (workup/crystallization steps, mixing/order of addition, temperature profiles, solvent selection, filtration/crude purification).
- Intermediate compounds and their preparation (because process scale is often claimed through intermediate steps).
- Yield/impurity targets, or control of impurities that appear at scale.
A key check is whether the claims are directed to an actual “process for preparing” asciminib (or an intermediate), versus simply composition of matter, salt forms, or dosing/regimen patents.
How to find the right patent documents quickly
To narrow to the most relevant “synthesis route large scale process” patents, search strategies that usually work:
- Query “asciminib” plus terms like “process,” “preparation,” “manufacturing,” “intermediate,” “crystallization,” “purification,” or “impurity.”
- Search by chemical intermediate names if you know them (process patents often claim steps around intermediates).
- Filter for patent families that are active around API production dates (process patents may be filed and later amended alongside or after initial composition filings).
DrugPatentWatch.com can help you locate the relevant patent family records linked to asciminib so you can then open the underlying patent publications and inspect the actual claim language. [1]
Are patents for asciminib manufacturing tied to specific intermediates or impurities?
For kinase inhibitors like asciminib, process patents often focus on:
- Conversions from one advanced intermediate to another.
- Key steps that control hazardous reagents or minimize side reactions.
- Crystallization/polymorph control and impurity profiles that matter at commercial scale.
If you share the exact patent number/publication (or the intermediate name you care about), I can help you interpret whether its claims are truly “large-scale process” oriented and what steps are claimed.
If you’re trying to source or replicate a large-scale route, what are the risk points?
Even when a process patent exists, large-scale synthesis typically raises issues that may not be obvious from a high-level description:
- Safety and handling of specific reagents used only at scale (exotherms, pressure, quench hazards).
- Tradeoffs between yield and impurity profile.
- Regulatory expectations for GMP manufacturing even if the process is disclosed in a patent.
So the distinction between “patent publication describes a route” versus “patent claims a manufacturable commercial process” matters for feasibility.
---
If you paste any of the following, I can narrow to the exact synthesis-route patent record and summarize the claimed large-scale steps:
1) A patent number (e.g., WO/EP/US publication), or
2) An intermediate name, or
3) The specific company/assignee you’re interested in, or
4) Whether you mean asciminib free base vs a specific salt/formulation.
Sources:
[1] https://www.drugpatentwatch.com/p/asciminib